E3 PreliminaryPreliminaryPEM ?ObservationalPeer-reviewedMachine draft
Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome.
Kuratsune, H, Yamaguti, K, Sawada, M et al. · International journal of molecular medicine · 1998 · DOI
Quick Summary
This study found that most ME/CFS patients in Japan had lower-than-normal levels of a hormone called DHEA-S, which is made by the adrenal glands. DHEA-S helps regulate mood, memory, stress response, sleep, and anxiety. The researchers suggest that low DHEA-S levels might explain some of the brain-related symptoms ME/CFS patients experience, like depression and cognitive problems.
Why It Matters
This research provides a potential biological explanation for the depression, anxiety, cognitive dysfunction, and sleep disturbances commonly reported by ME/CFS patients. If DHEA-S deficiency is confirmed as pathogenic in larger studies, it could lead to targeted hormonal interventions and validate the role of endocrine dysfunction in ME/CFS pathogenesis.
Observed Findings
- Majority of Japanese CFS patients demonstrated serum DHEA-S deficiency compared to controls
- DHEA-S is one of the most abundantly produced hormones from the adrenal glands
- DHEA-S functions as a neurosteroid affecting memory, stress response, anxiety, sleep, and depression
- CFS patients show evidence of impaired HPA axis activation
Inferred Conclusions
- DHEA-S deficiency may be associated with abnormalities in the endocrine system in CFS
- Low DHEA-S levels may contribute to the neuropsychiatric symptoms observed in CFS patients
- Endocrine dysfunction, particularly involving adrenal hormone production, may play a role in CFS pathogenesis
Remaining Questions
- Does DHEA-S deficiency occur in CFS populations outside Japan, and is the finding population-specific?
- Is low DHEA-S a primary pathogenic mechanism or a secondary effect of chronic illness?
- Would DHEA-S supplementation improve neuropsychiatric symptoms or overall CFS outcomes?
- How does DHEA-S deficiency correlate with symptom severity, disease duration, and other neuroendocrine abnormalities?
What This Study Does Not Prove
This study does not prove that DHEA-S deficiency causes ME/CFS symptoms—it only shows an association. It does not establish whether low DHEA-S is a primary driver of disease, a secondary consequence of CFS, or an epiphenomenon. The findings are limited to a Japanese population and may not generalize globally. Additionally, single-timepoint hormone measurements do not clarify whether deficiency is persistent or fluctuating.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.3892/ijmm.1.1.143
- PMID
- 9852212
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026